| John C Marsh, MD | |
|
619 Sw Corporate View, Topeka, KS 66615-1233 | |
| (785) 235-3322 | |
| (785) 246-6258 |
| Full Name | John C Marsh |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 619 Sw Corporate View, Topeka, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588774145 | NPI | - | NPPES |
| 100306510A | Medicaid | KS | |
| 180029280 | Other | KS | PALMETTO GBA |
| 051838 | Other | KS | BCBS OF KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 04-26915 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John C Marsh, MD 619 Sw Corporate View, Topeka, KS 66615-1233 Ph: (785) 235-3322 | John C Marsh, MD 619 Sw Corporate View, Topeka, KS 66615-1233 Ph: (785) 235-3322 |
News Archive
Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent.
Pfizer's Lipitor, a blood cholesterol lowering drug, is a popular one the among general population. However now that a generic competition for the drug has arrived in the market the company has devised discounts and incentives for patients, insurers and companies that process prescriptions that will, at least for the next six months, make the brand name drug about as cheap as or cheaper than the generics.
Accuray Incorporated, a global leader in the field of radiosurgery, announced today it received Shonin approval from the Japanese Ministry of Health, Labor and Welfare to market the CyberKnife G4 Robotic Radiosurgery System to treat tumors non-invasively anywhere in the body, inclusive of head and neck. The System will be marketed in Japan as the "CyberKnife Radiosurgery System."
A study of Italians who consume a diet rich in resveratrol — the compound found in red wine, dark chocolate and berries — finds they live no longer than and are just as likely to develop cardiovascular disease or cancer as those who eat or drink smaller amounts of the antioxidant.
Exploration of new leukemia antigens and construction of appropriate delivery systems using FDA-approved material are important strategies for developing leukemia vaccines for clinic use.
› Verified 2 days ago
Trent L. Vande Garde, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 619 Sw Corporate View, Topeka, KS 66615 Phone: 785-235-3322 Fax: 785-235-1217 | |
Walter Dan Weaver, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 619 Sw Corporate View, Topeka, KS 66615 Phone: 785-235-3322 Fax: 785-246-6258 | |
Rita R. Tablante, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 619 Sw Corporate View, Topeka, KS 66615 Phone: 785-235-3322 Fax: 785-246-6258 | |
Thomas J Ashley, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1616 Sw 8th Ave, Topeka, KS 66606 Phone: 785-233-2280 Fax: 785-233-6918 | |
Randall J Kresie, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 6001 Sw 6th Ave, Suite 210, Topeka, KS 66615 Phone: 785-233-0011 Fax: 785-233-1292 | |
Dr. Babak Marefat, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 823 Sw Mulvane St, Topeka, KS 66606 Phone: 785-354-9591 | |
Dr. Gray W Woods, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1500 Sw 10th Ave, Topeka, KS 66604 Phone: 785-354-5613 Fax: 785-354-6426 |